| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/04/2013 | CN103275186A Polypeptide having kidney protection effect, and application thereof |
| 09/04/2013 | CN103275185A Matrix metal proteinase-2 polypeptide inhibitors and application thereof |
| 09/04/2013 | CN103275184A Matrix metal proteinase-2 polypeptide inhibitors and application thereof |
| 09/04/2013 | CN103275183A VEGFR2 tyrosine kinase inhibitor polypeptide 2 and application thereof |
| 09/04/2013 | CN103275181A Tuna ground meat polypeptide angiogenesis inhibiting factor as well as preparation method and application thereof |
| 09/04/2013 | CN103275180A Navodon septentrionalos fish head protein antioxidant peptide as well as preparation method and application thereof |
| 09/04/2013 | CN103275179A Small peptide reducing blood pressure and having renin and ACE double inhibitory activity, and preparation method and application of small peptide |
| 09/04/2013 | CN103275177A Small peptide having renin and ACE double inhibitory activity, and preparation method and application of small peptide |
| 09/04/2013 | CN103275159A Modified 2' and 3' -nucleoside produgs for treating flaviridae infections |
| 09/04/2013 | CN103272234A Pharmaceutical compositions |
| 09/04/2013 | CN103272227A Peptides for desensibilization against allergens |
| 09/04/2013 | CN103272226A Pharmaceutical composition for controlling poultry mould infection |
| 09/04/2013 | CN103272225A Crystallized oxalate decarboxylase and methods of use |
| 09/04/2013 | CN103272224A Lysozyme sugar lozenge and preparation method thereof |
| 09/04/2013 | CN103272223A Oxidation prevention health care capsule and preparation method thereof |
| 09/04/2013 | CN103272222A Application of nerve growth factor (NGF) to preparation of medicament for preventing/treating neurotic alopecia |
| 09/04/2013 | CN103272221A Applications of WSB-1 protein in preparing drugs for treating osteosarcoma |
| 09/04/2013 | CN103272220A Buserelin acetate lipid microbubble and preparation method thereof |
| 09/04/2013 | CN103272219A Selective r-cadherin antagonists and methods |
| 09/04/2013 | CN103272218A Preparation method of copper (II)-(fatty acyl glycyl aspartyl histidine) complex and SOD (Superoxide Dismutase)-like activity research of complex |
| 09/04/2013 | CN103272217A Pleurotus abalones protein extract and applications thereof for resisting tumor |
| 09/04/2013 | CN103272216A Pleurotus citrinopileatus protein extractive and application thereof in tumor resisting |
| 09/04/2013 | CN103272215A Pleurotus djamor protein extract and applications thereof for resisting tumor |
| 09/04/2013 | CN103272214A Flammulina velutipes protein extract and applications thereof for resisting tumor |
| 09/04/2013 | CN103272213A Cordyceps militaris protein extract and antitumor application thereof |
| 09/04/2013 | CN103272212A Clitocybe maxima protein extract and applications thereof for resisting tumor |
| 09/04/2013 | CN103271871A Recombinant human interferon injection and preparation method thereof |
| 09/04/2013 | CN103271340A Nanoscale health-care food capable of removing heavy metal in human body and preparation method thereof |
| 09/04/2013 | CN102940882B Medicine for treating respiratory diseases |
| 09/04/2013 | CN102836126B Preparation method of artificial red blood cell universal for animals |
| 09/04/2013 | CN102824630B Pharmaceutical composition for treating chicken proventriculitis and preparation method of pharmaceutical composition |
| 09/04/2013 | CN102816769B Hermetia illucens L antibacterial peptide, preparation method and application thereof |
| 09/04/2013 | CN102657875B ANT1 gene-based targeted immunoliposome, preparation method thereof and application thereof |
| 09/04/2013 | CN102657599B Method for preparing bioactive injectable hydrogel materials for oncotherapy |
| 09/04/2013 | CN102580063B Preparation method of xanthine oxidase inhibitor |
| 09/04/2013 | CN102533918B Method for preparing rapeseed active polypeptides |
| 09/04/2013 | CN102260324B Inflammation prophase chemotactic factor antagonistic peptide, preparation method thereof, and application thereof |
| 09/04/2013 | CN102258765B Preparation method of colistin sulfate premix |
| 09/04/2013 | CN102250935B Recombinant transgenic vector carrying human insulin-like growth factor-I and use thereof |
| 09/04/2013 | CN101987868B Derivative or pharmaceutically acceptable salt of GLP-1 analogue and application of derivative or pharmaceutically-acceptable salt of a GLP-1 analogue |
| 09/04/2013 | CN101861335B Manufacture, compositions and uses of coagulationfactor VIIA modulator |
| 09/04/2013 | CN101687908B Antigen determinant of rheumatoid arthritis-specific autoantibody and use thereof |
| 09/04/2013 | CN101633689B Peptide selection method |
| 09/04/2013 | CN101506359B Method for producing lipase, transformed yarrowia lipolytica cell capable of producing said lipase and their uses |
| 09/04/2013 | CN101505787B Treatment of cartilage disorders |
| 09/04/2013 | CN101505783B Acetylated amino acids as anti-platelet agents, nutritional and vitamin supplements |
| 09/04/2013 | CN101460188B Treatment of ischemic disease using erythropoietin |
| 09/04/2013 | CN101269214B EG-VEGF nucleotide and using method |
| 09/04/2013 | CN101151043B Composition and methods for promoting wound healing and tissue regeneration |
| 09/03/2013 | US8524879 RNA interference suppresion of neurodegenerative diseases and methods of use thereof |
| 09/03/2013 | US8524872 Nucleic acids and corresponding proteins entitled 158P3D2 useful in treatment and detection of cancer |
| 09/03/2013 | US8524871 Modified gherlin peptides |
| 09/03/2013 | US8524868 Polypeptide fragments of the hepatitis E virus, the vaccine composition comprising said fragments and the diagnostic kits |
| 09/03/2013 | US8524866 Antibodies to the alpha-7 nicotinic receptors and methods of treating inflammatory disorders with the same |
| 09/03/2013 | US8524862 Muteins of C5a anaphylatoxin and methods of inhibiting C5a |
| 09/03/2013 | US8524861 Treatment of bacterial infections |
| 09/03/2013 | US8524779 Emulsion compositions containing quaternary ammonium compounds |
| 09/03/2013 | US8524688 Use of sulfated glycosaminoglycans for establishing effective labor in women |
| 09/03/2013 | US8524676 Method for treating enterovirus or rhinovirus infection using antisense antiviral compounds |
| 09/03/2013 | US8524674 Method of improving the conditioned reflex habit, the muscle tonus, or the motion coordination of a patient after suffering trauma to the brain cortex |
| 09/03/2013 | US8524673 Pharmaceutical formulation |
| 09/03/2013 | US8524672 Method for inhibiting BAFF-R activity |
| 09/03/2013 | US8524671 Cyclosporin derivatives for treating inflammatory diseases and conditions |
| 09/03/2013 | US8524670 Engineered CXCL12 alpha locked dimer polypeptide |
| 09/03/2013 | US8524668 Methods of protecting against apoptosis using lipopeptides |
| 09/03/2013 | US8524666 Methods of using vimentin to inhibit angiogenesis and endothelial cell proliferation |
| 09/03/2013 | US8524665 Use of secretin in treatments of disorders associated with the amygdala |
| 09/03/2013 | US8524664 Methods of treating overproduction of cortisol using ACTH antagonist peptides |
| 09/03/2013 | US8524663 Method for site-specific polyvalent display on polymers |
| 09/03/2013 | US8524662 Compositions and methods for treating joints |
| 09/03/2013 | US8524661 Inhibiting serum response factor (SRF) to improve glycemic control |
| 09/03/2013 | US8524660 Polyalkylene polymer compounds and uses thereof |
| 09/03/2013 | US8524659 RNA virus-derived peptides with modified side chains |
| 09/03/2013 | US8524658 Lactoferrin and brain health and development in infants |
| 09/03/2013 | US8524657 Peptidic compounds |
| 09/03/2013 | US8524656 GM-CSF and truncated CCL2 conjugates and methods and uses thereof |
| 09/03/2013 | US8524655 Use of SCF and G-CSF in the treatment of cerebral ischemia and neurological disorders |
| 09/03/2013 | US8524654 Prolyl endopeptidase inhibitors for reducing or preventing neutrophilic inflammation |
| 09/03/2013 | US8524653 Peptidomimetic macrocycles |
| 09/03/2013 | US8524652 Chimeric polypeptide comprising the fragment B of shiga toxin and peptides of therapeutic interest |
| 09/03/2013 | US8524491 Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated |
| 09/03/2013 | US8524460 PSCA: prostate stem cell antigen and uses thereof |
| 09/03/2013 | US8524446 Method for detecting adeno-associated virus |
| 09/03/2013 | US8524270 Cross-linked gelatin composition coated with a wetting agent |
| 09/03/2013 | US8524251 Neisseria meningitidis antigens and compositions |
| 09/03/2013 | US8524248 Methods to diagnose and immunize against the virus causing human Merkel cell carcinoma |
| 09/03/2013 | US8524246 Treatment of immune disease by mucosal delivery of antigents using genetically modified Lactobacillus |
| 09/03/2013 | US8524244 Targeted therapeutics based on engineered proteins that bind EGFR |
| 09/03/2013 | US8524240 Diagnosis and therapy of hematological malignancies |
| 09/03/2013 | US8524232 Methods of treatment using taci-immunoglobulin fusion proteins |
| 09/03/2013 | US8524226 Methods of prolonging patency of hemodialysis access |
| 09/03/2013 | US8524225 Use of proline specific endoproteases to hydrolyse peptides and proteins |
| 09/03/2013 | US8524220 Protease inhibitor: protease sensitivity expression system composition and methods improving the therapeutic activity and specificity of proteins delivered by bacteria |
| 09/03/2013 | US8524217 MCP1-Ig fusion variants |
| 09/03/2013 | CA2736921C Tumour-associated peptides that bind to mhc molecules |
| 09/03/2013 | CA2707767C Biologically active peptides |
| 09/03/2013 | CA2654440C Methods for treatment or prophylaxis of atherosclerosis and reperfusion injury |
| 09/03/2013 | CA2606939C Polymeric derivative of cytidine metabolic antagonist |
| 09/03/2013 | CA2565084C Use of sulglicotide for the treatement of mucositis |
| 09/03/2013 | CA2561696C Novel modified galectin 9 proteins and use thereof |